Drug-drug interactions in oncology - prevalence and clinical relevance

被引：0
|
作者：
Hinnerkort, A. [1 ,2 ]
Liekweg, A. [1 ]
Muellerleile, U. [3 ]
Tiede, S. [3 ]
Bruellke, N. [3 ]
Jaehde, U. [2 ]
机构：
[1] Asklepios Kliniken Hamburg GmbH, Dept Pharm, Hamburg, Germany
[2] Univ Bonn, Dept Clin Pharm, Inst Pharm, D-5300 Bonn, Germany
[3] Asklepios Klin Barmbek, Dept Oncol & Pallit Med, Hamburg, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [31] Drug-drug interactions in oncology: Why are they important and can they be minimized?
    Blower, P
    de Wit, R
    Goodin, S
    Aapro, M
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 55 (02) : 117 - 142
  • [32] Venlafaxine drug-drug interactions in clinical practice
    Benazzi, F
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1998, 23 (03): : 181 - 182
  • [33] The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug-Drug Interactions: Drug-Gene, Drug-Gene-Gene and Drug-Drug-Gene Interactions
    Hahn, Martina
    Roll, Sibylle C.
    PHARMACEUTICALS, 2021, 14 (05)
  • [34] Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients
    Zhang, Jiali
    Ma, Danyi
    Chen, Meng
    Hu, Yanting
    Chen, Xveying
    Chen, Jingyu
    Huang, Man
    Dai, Haibin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study
    Baecke, C.
    Gyssens, I. C.
    Decoutere, L.
    van der Hilst, J. C. H.
    Messiaen, P.
    NETHERLANDS JOURNAL OF MEDICINE, 2017, 75 (06): : 235 - 240
  • [36] P-Glycoprotein-based drug-drug interactions: preclinical methods and relevance to clinical observations
    Adorjan Aszalos
    Archives of Pharmacal Research, 2004, 27 : 127 - 135
  • [37] Clinical and toxicological relevance of CYP2C9: Drug-drug interactions and pharmacogenetics
    Rettie, AE
    Jones, JP
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 : 477 - 494
  • [38] P-glycoprotein-based drug-drug interactions: Preclinical methods and relevance to clinical observations
    Aszalos, A
    ARCHIVES OF PHARMACAL RESEARCH, 2004, 27 (02) : 127 - 135
  • [39] SILDENAFIL AND FUROSEMIDE ASSOCIATED OTOTOXICITY: CONSIDERATION OF DRUG-DRUG INTERACTIONS, SYNERGY, AND BROADER CLINICAL RELEVANCE
    Skeith, Leslie
    Yamashita, Cory
    Mehta, Sanjay
    Farquhar, Donald
    Kim, Richard B.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2013, 20 (02): : E128 - E131
  • [40] DRUG-DRUG INTERACTIONS
    FORTH, W
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (NA1): : 108 - 114
12345